Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $160.34 million. The enterprise value is $164.55 million.
| Market Cap | 160.34M |
| Enterprise Value | 164.55M |
Important Dates
The last earnings date was Friday, May 1, 2026, after market close.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 129.31 million shares outstanding. The number of shares has increased by 10.88% in one year.
| Current Share Class | 129.31M |
| Shares Outstanding | 129.31M |
| Shares Change (YoY) | +10.88% |
| Shares Change (QoQ) | +2.49% |
| Owned by Insiders (%) | 46.98% |
| Owned by Institutions (%) | 2.48% |
| Float | 68.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3,232.69 |
| P/TBV Ratio | 3,232.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 8.77.
| Current Ratio | 0.76 |
| Quick Ratio | 0.72 |
| Debt / Equity | 8.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,174.00 |
Financial Efficiency
Return on equity (ROE) is -924.32% and return on invested capital (ROIC) is -580.55%.
| Return on Equity (ROE) | -924.32% |
| Return on Assets (ROA) | -115.96% |
| Return on Invested Capital (ROIC) | -580.55% |
| Return on Capital Employed (ROCE) | -7,388.81% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.84M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.22% in the last 52 weeks. The beta is 0.44, so TLSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -16.22% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 49.85 |
| Average Volume (20 Days) | 208,071 |
Short Selling Information
The latest short interest is 1.57 million, so 4.31% of the outstanding shares have been sold short.
| Short Interest | 1.57M |
| Short Previous Month | 1.59M |
| Short % of Shares Out | 4.31% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.63 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.13M |
| Pretax Income | -18.43M |
| Net Income | -18.43M |
| EBITDA | -21.12M |
| EBIT | -21.13M |
| Earnings Per Share (EPS) | -$0.16 |
Balance Sheet
The company has $4.01 million in cash and $456,000 in debt, with a net cash position of $3.55 million or $0.03 per share.
| Cash & Cash Equivalents | 4.01M |
| Total Debt | 456,000 |
| Net Cash | 3.55M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 52,000 |
| Book Value Per Share | 0.00 |
| Working Capital | -2.66M |
Cash Flow
In the last 12 months, operating cash flow was -$12.85 million and capital expenditures -$21,000, giving a free cash flow of -$12.87 million.
| Operating Cash Flow | -12.85M |
| Capital Expenditures | -21,000 |
| Depreciation & Amortization | 12,000 |
| Net Borrowing | -196,000 |
| Free Cash Flow | -12.87M |
| FCF Per Share | -$0.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.88% |
| Shareholder Yield | -10.88% |
| Earnings Yield | -10.96% |
| FCF Yield | -7.65% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |